Press release
Chagas Disease Market is expected to reach US$ 467 million by 2031, growing with a CAGR of 7.2% | Bayer AG, Novartis AG, Laboratorio Elea Phoenix.
Chagas Disease Market
Chagas Disease Market analysis, according to DataM Intelligence, offers more than just an overview, it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Get a Free Sample PDF copy of the report - https://datamintelligence.com/download-sample/chagas-disease-market
The Chagas Disease market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
Chagas disease, caused by the Trypanosoma cruzi parasite, is transmitted through insect bites or contaminated food. Symptoms range from mild to severe, affecting the heart and digestive system. Treatment includes antiparasitic drugs and supportive therapies. Public health initiatives focus on vector control and early diagnosis. It is endemic in Latin America but increasingly seen globally.
Forecast Growth Projected:
The Global Chagas Disease Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Chagas Disease Market:
Bayer AG, Novartis AG, Laboratorio Elea Phoenix, Maprimed, Nortec Quimica SA, Upsher-Smith Laboratories, Inc., Merck and Co., ChemFish Tokyo Co., Ltd., Anant Pharmaceuticals Pvt. Ltd., and InBios International Inc.
Segment Covered in the Chagas Disease Market:
By Type: Acute Chagas Disease, Chronic Chagas Disease.
By Drugs: Benznidazole , Nifurtimox, Others.
By Route of administration: Oral , Parenteral.
By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies.
Industry Development:
In February 2024, Brazil's federal government, in partnership with the World Health Organization (WHO), launched the Healthy Brazil program. This initiative is a public policy aimed at combating 14 diseases that predominantly affect socially vulnerable populations, including malaria, Chagas disease, HIV, and tuberculosis. The program seeks to either eliminate these conditions as public health concerns or significantly reduce their incidence, showcasing a commitment to improving health equity in Brazil.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=chagas-disease-market
Regional Break out:
The global Chagas Disease Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Chagas Disease manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Chagas Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Speak to Our Senior Analyst and Get Customization in the report as per your requierments: https://datamintelligence.com/customize/chagas-disease-market
Frequently asked questions:
➠ What is the global sales value, production value, consumption value, import and export of Chagas Disease market?
➠ Who are the global key manufacturers of the Chagas Disease Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?
➠ What are the Chagas Disease market opportunities and threats faced by the vendors in the global Chagas Disease Industry?
➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➠ What focused approach and constraints are holding the Chagas Disease market?
➠ What are the different sales, marketing, and distribution channels in the global industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chagas Disease Market is expected to reach US$ 467 million by 2031, growing with a CAGR of 7.2% | Bayer AG, Novartis AG, Laboratorio Elea Phoenix. here
News-ID: 3824194 • Views: …
More Releases from DataM Intelligence 4market Research LLP
US Artificial Insemination Market to Grow at 7.20% CAGR, Driven by Rising Demand …
According to DataM Intelligence, the United States artificial insemination market is projected to register a growth rate of 7.20% during the forecast period of 2025-2033. Increasing adoption of artificial insemination among single individuals and same-sex couples to achieve pregnancy, demand for less invasive and cost-effective alternatives to IVF, and greater awareness regarding assisted reproductive technologies are major factors driving steady market expansion.
Artificial insemination bypasses certain natural reproductive barriers, such as…
AI in Oncology Market to Hit USD 11.52 Billion by 2030 Amid Rapid Advances in Ca …
According to DataM Intelligence, the global AI in oncology market was valued at USD 2.45 billion in 2024 and is projected to reach USD 11.52 billion by 2030, growing at a CAGR of 29.4% during the forecast period. The increasing prevalence of cancer, coupled with the rapid integration of artificial intelligence in cancer diagnosis, treatment planning, and drug discovery, is driving robust market expansion. AI tools in oncology accelerate diagnostic…
US Blockchain in Insurance Market to Reach USD 12.5 Billion by 2035 at 25.81% CA …
According to DataM Intelligence, the US Blockchain in Insurance market is projected to increase from USD 1 billion in 2024 to USD 12.5 billion by 2035, reflecting a remarkable CAGR of 25.81%. The growth is driven by the industry's strong commitment to transparency, efficiency, and fraud reduction. Insurers are rapidly adopting blockchain technology to streamline claims processes, enhance risk management, and comply with stringent regulatory standards governing customer data and…
US Animal Feed Additives Market to Reach USD 31.17 Billion by 2035 Driven by Sus …
The USA animal feed additives market, according to DataM Intelligence, is valued at USD 16,097.3 million in 2025 and is forecasted to reach USD 31,169.3 million by 2035, growing at a CAGR of 6.8%. The rising demand for functional, nutrient-enriched, and safe animal feed products is driving this sustained growth. Increased awareness regarding livestock well-being, high-quality meat and dairy production, and rising focus on sustainable farming practices continue to shape…
More Releases for Chagas
Chagas Disease Market Emerging Trends and Growth Prospects 2034
Introduction
Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening parasitic illness caused by Trypanosoma cruzi. It is transmitted primarily through triatomine bugs (kissing bugs), blood transfusions, congenital infections, or contaminated food. Once considered confined to Latin America, globalization, migration, and increased travel have made Chagas disease a global public health concern.
While millions are infected worldwide, the disease remains classified as a neglected tropical disease (NTD), with limited treatment…
Chagas Disease Treatment Market: An In-Depth Analysis
The global Chagas Disease Treatment Market was valued at approximately USD 450 million in 2024 and is projected to reach around USD 700 million by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033 .
Chagas Disease Treatment Market Overview
Chagas disease, caused by the Trypanosoma cruzi parasite, remains a significant public health challenge, particularly in Latin America. The market's growth is driven by increasing awareness,…
Chagas Disease Drug Market Size, Share, Growth Forecast 2023-2032
Chagas disease, caused by the parasite Trypanosoma cruzi, remains a significant public health concern, particularly in Latin America. With an estimated 6 to 7 million people worldwide affected by this neglected tropical disease, the demand for effective treatments has spurred the growth of the Chagas Disease Drug Market. As of 2022, the market size stood at a commendable USD 265.2 million, and projections indicate a robust expansion, with expectations to…
2018 – 2024 Chagas Disease Management Market | Global Industry Report
2018 – 2024 Chagas Disease Management Market | Global Industry Report
A Recent Market Study On Chagas Disease And Its Current Trends And Future Insights
Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by Trypanosoma cruzi. It is transmitted by kissing bugs or triatomine bugs. It can also be transmitted through blood transfusions, in pregnancy, and organ transplantation. In early stage of the Chagas disease, the symptoms include swollen…
Chagas Disease Treatment Market Global Industry Insights, and Forecast till 2025
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America,…
Chagas Disease Treatment Market - Global Industry Insights, and Forecast till 20 …
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America,…
